Skip to main content

Statera Biopharma, Inc. (STAB)

NASDAQ: STAB · IEX Real-Time Price · USD
3.34 -0.18 (-5.11%)
Nov 26, 2021 1:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2020201920182017201620152014201320122011
Revenue
0.261.111.141.953.522.713.78.493.578.79
Revenue Growth
-76.38%-2.18%-41.58%-44.62%29.92%-26.84%-56.39%137.71%-59.38%-
Gross Profit
0.261.111.141.953.522.713.78.493.578.79
Selling, General & Admin
2.161.822.322.53.386.368.4712.0411.1211.11
Research & Development
0.691.663.625.056.57.149.6519.5322.522.79
Operating Expenses
2.853.475.947.559.8713.518.1231.5633.6233.9
Operating Income
-2.59-2.36-4.8-5.6-6.36-10.79-14.42-23.08-30.05-25.11
Interest Expense / Income
0000001.09000
Other Expense / Income
-0.190.29-1.194.11-3.71.85-17.14-5.81-11.81-21.09
Pretax Income
-2.4-2.65-3.61-9.71-2.66-12.641.63-17.26-18.23-4.01
Net Income
-2.4-2.65-3.61-9.71-2.66-12.641.63-17.26-18.23-4.01
Net Income Common
-2.4-2.65-3.61-9.71-2.66-12.641.63-17.26-18.23-4.01
Shares Outstanding (Basic)
121111111173222
Shares Outstanding (Diluted)
121111111173222
Shares Change
9.72%0.04%0.91%1.87%55.62%161.22%20.12%20.36%14.82%-
EPS (Basic)
-0.19-0.23-0.32-0.87-0.24-1.790.60-7.67-9.75-2.40
EPS (Diluted)
-0.19-0.23-0.32-0.87-0.24-1.790.60-7.67-9.75-2.40
Free Cash Flow Per Share
-0.19-0.23-0.41-0.59-0.44-1.71-5.36-10.33-11.14-10.79
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-983.70%-212.03%-421.72%-287.46%-180.65%-398.45%-389.58%-271.88%-841.47%-285.60%
Profit Margin
-912.16%-237.73%-317.34%-498.19%-75.57%-466.64%44.01%-203.38%-510.66%-45.66%
Free Cash Flow Margin
-902.47%-234.84%-404.60%-339.10%-137.87%-445.83%-391.03%-273.82%-583.30%-199.78%
EBITDA
-2.39-2.63-3.59-9.69-2.6-12.363.56-16.79-17.75-3.49
EBITDA Margin
-907.81%-236.50%-315.75%-497.10%-73.77%-456.48%96.16%-197.83%-497.23%-39.68%
EBIT
-2.4-2.65-3.61-9.71-2.66-12.642.72-17.26-18.23-4.01
EBIT Margin
-912.16%-237.73%-317.34%-498.19%-75.57%-466.64%73.44%-203.38%-510.66%-45.66%
Showing 10 of 17 years
7 more years are available
Start Free Trial
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).